Viewing Study NCT00776503


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-06-01 @ 12:09 AM
Study NCT ID: NCT00776503
Status: COMPLETED
Last Update Posted: 2014-03-20
First Post: 2008-10-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia
Sponsor: Groupe Francophone des Myelodysplasies
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Epigenetic View
None Myelodysplasia View
None Cytarabine View